Oklahoma · 2026
HB 1416
Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.
Bill record: Open States bulk CSV (bills/votes) CC0-1.0
Issue tags AI-classified
Classified by a local model from the bill's text; confidence shown. GovTally LLM enrichment (local oMLX)
Sponsors
- Josh West Republican lead
- Paul Rosino Republican lead
Roll-call votes on this bill
| Question | Chamber | Result | Yea | Nay | Other | Date | Source |
|---|---|---|---|---|---|---|---|
| Third Reading | lower | pass | 86 | 7 | 2 | Mar 3, 2025 | Open States bulk CSV (bills/votes) CC0-1.0 |
| Health And Human Services Oversight Committee: Do Pass As Amended By Cs | lower | pass | 9 | 0 | 0 | Feb 26, 2025 | Open States bulk CSV (bills/votes) CC0-1.0 |
| Public Health Committee: Do Pass | lower | pass | 6 | 0 | 0 | Feb 5, 2025 | Open States bulk CSV (bills/votes) CC0-1.0 |